Lindborg Stacy
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Lindborg Stacy. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| IMNN | President and CEO | Option Exercise | 1,667 | — | — | Sep 6, 2025 |
| BCLI | Award / Grant | 20,000 | — | — | Jan 1, 2025 | |
| IMNN | President and CEO | Purchase | 25,000 | $0.98 | $24,500 | Aug 15, 2024 |
| BCLI | Co-Chief Executive Officer | Award / Grant | 241,935 | — | — | Mar 11, 2024 |
| BCLI | Co-Chief Executive Officer | Purchase | 11,500 | $1.77 | $20,355 | Sep 1, 2023 |
| BCLI | Co-Chief Executive Officer | Award / Grant | 35,000 | — | — | Aug 2, 2023 |
| BCLI | Co-Chief Executive Officer | Award / Grant | 75,000 | — | — | Apr 20, 2023 |
| BCLI | Co-Chief Executive Officer | Award / Grant | 35,000 | — | — | Dec 7, 2022 |
| BCLI | EVP, Head Global Clin Research | Award / Grant | 25,000 | — | — | Jun 1, 2020 |